L’ADN du Traitement : Combattre la Crise des Opioïdes au Canada

Authors

  • Tina Shaghaeefallah Western University

DOI:

https://doi.org/10.18192/uojm.v15iS2.7537

Keywords:

ADN, opioïdes, Canada

References

1. Government of Canada. Federal actions on the overdose crisis [Internet]. [place unknown]: 2024 Jun [updated 2024 Jun 28; cited 2024 Aug 16]. Available from: https://www.canada.ca/en/health-canada/services/opioids/federal-actions/overview.html

2. Belzak L, Halverson J. Evidence synthesis - the opioid crisis in Canada: A national perspective. Health Promotion and Chronic Disease Prevention in Canada. 2018 Jun;38(6):224–33.

3. Fischer B, Pang M, Tyndall M. The Opioid Death Crisis in Canada: Crucial Lessons for Public Health. The Lancet Public Health. 2018 Dec 19;4(2).

4. House of Commons Canada. GOVERNMENT RESPONSE TO THE REPORT OF THE STANDING COMMITTEE ON HEALTH ENTITLED Report and Recommendations on the Opioid Crisis in Canada [Internet]. [place unknown]: [cited 2024 Aug 16]. Available from: https://www.ourcommons.ca/

5. Government of Canada. Characteristics of patients with repeat hospitalizations for substance-related harms in Canada [Internet]. [place unknown]: [updated 2023 Sep 28; cited 2024 Aug 16]. Available from:https://www.canada.ca/en/health-canada/services/opioids/data-surveillance-research/characteristics-patients-repeat-hospitalizations-substance-related-harms-canada.html

6. Eapen-John D, Mohiuddin AG, Kennedy JL. A potential paradigm shift in opioid crisis management: The role of pharmacogenomics. The World Journal of Biological Psychiatry. 2022 Jan 14;23(6):411–23.

7. Smith DM, Stevenson JM, Ho TT, Formea CM, Gammal RS, Cavallari LH. Pharmacogenetics: A precision medicine approach to combating the opioid epidemic. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2021 Dec 19;5(2):239–50.

8. Tyndale RF, Droll KP, Sellers1 EM. Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence. Pharmacogenetics. 1997 Oct;7(5):375–9.

9. Bright D, Petry N, Roath E, Reckow E, Chavour S. Barriers, solutions, and effect of using pharmacogenomics data to support opioid prescribing. Journal of Managed Care & Specialty Pharmacy. 2020 Dec;26(12):1597–602.

10. Substance Use Costs in Canada in 2020 [Internet]. [cited 2024 Aug 16]. Available from: https://csuch.ca/substance-use-costs/current-costs/

Downloads

Published

2025-08-05

Issue

Vol. 15 No. S2 (2025): UOJM Commentary Contest 2024

Section

Commentary

License

Copyright (c) 2025 Tina Shaghaeefallah

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

  1. Authors publishing in the UOJM retain copyright of their articles, including all the drafts and the final published version in the journal.
  2. While UOJM does not retain any rights to the articles submitted, by agreeing to publish in UOJM, authors are granting the journal right of first publication and distribution rights of their articles.
  3. Authors are free to submit their works to other publications, including journals, institutional repositories or books, with an acknowledgment of its initial publication in UOJM.
  4. Copies of UOJM are distributed both in print and online, and all materials will be publicly available online. The journal holds no legal responsibility as to how these materials will be used by the public.
  5. Please ensure that all authors, co-authors and investigators have read and agree to these terms.
  6. Works are  licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.